In these experiments, 2 μM AF mimicked the paraptosis-sensitizing effect of TrxR1 knockdown in Bz-treated cells (Fig. 2F–I), indicating that 2 μM AF may inhibit TrxR1 as a major target. The gene discussed is TXNRD1; the disease is atrial fibrillation.